Launch week offerEnds in00h00m00s

annual Promonthly Pro

Mikael S. Lindström

Has grant

Researcher, Docent (Associate Professor)

Karolinska Institutet

Sweden

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Professors in Sweden Professors in Cell Biology Cell Biology professors in Sweden

About

Dr. Mikael S. Lindström is a Researcher and Docent at Karolinska Institutet in Sweden. His research focuses on the intersection of ribosomal proteins and p53 regulation, as well as the impact of chromatin damage on RNA Polymerase II. Recent publications highlight his work on glioma therapeutic strategies and the roles of ribosome biogenesis in cancer cell growth.

Recent Grants

Grant: Open

Elucidating and exploiting genome instability and ribosomal deregulation in glioma growth and treatment.

Open Date: 2026-01-01

Close Date: 2028-12-01

Grant: Open

Međudjelovanje heterozigotne mutacije gena za ribosomski protein L24 i p53 u patogenezi bolesti

Open Date: 2023-12-27

Close Date: 2027-12-26

Grant: Close

Ribosome synthesis as a target for chemotherapy

Open Date: 2017-01-01

Close Date: 2019-01-01

Grant: Close

Function and expression of PROX1 in malignant brain tumors

Open Date: 2013-01-01

Close Date: 2017-01-01

Grant: Close

Ribosome synthesis as a target for chemotherapy

Open Date: 2013-01-01

Close Date: 2015-01-01

Articles (17)

Year:

2026

Year:

2026

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Year:

2020

Year:

2020

Collaborators (15)

Madhurendra Singh

Karolinska Institutet

SWEDEN

Mikael S. Lindström

Research Interests

Make your next move.

Explore related searches

About

Recent Grants

Articles (17)

JP-1302 inhibits RNA polymerase I transcription and induces nucleolar stress in cancer cell lines

The Many Faces of Glioblastoma-Associated Macrophages and Their Gene Signatures

Precise mapping of single-stranded DNA breaks by sequence-templated erroneous DNA polymerase end-labelling.

The Central Role of Ribosomal Proteins in p53 Regulation

Chromatin damage generated by DNA intercalators leads to degradation of RNA Polymerase II

Uncovering novel therapeutic avenues for glioma by exploring the functional interplay of FGFR1, p53, and ribosome biogenesis

Actionable cancer vulnerability due to translational arrest, p53 aggregation and ribosome biogenesis stress evoked by the disulfiram metabolite CuET

Small molecule-mediated disruption of ribosome biogenesis synergizes with FGFR inhibitors to suppress glioma cell growth

Inhibition of RNA Pol I transcription and induction of nucleolar stress in cancer cells treated with the experimental alpha-adrenergic receptor antagonist JP-1302

p53 at the crossroad of DNA replication and ribosome biogenesis stress pathways

Targeting Ribosome Biogenesis in Cancer: Lessons Learned and Way Forward

Correction to: SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma

SFRP2 induces a mesenchymal subtype transition by suppression of SOX2 in glioblastoma

The exon-junction complex helicase eIF4A3 controls cell fate via coordinated regulation of ribosome biogenesis and translational output

Thermal Proteome Profiling Identifies Oxidative-Dependent Inhibition of the Transcription of Major Oncogenes as a New Therapeutic Mechanism for Select Anticancer Compounds

The antimalarial drug amodiaquine stabilizes p53 through ribosome biogenesis stress, independently of its autophagy-inhibitory activity

Identification of functionally distinct and interacting cancer cell subpopulations from glioblastoma with intratumoral genetic heterogeneity.

Collaborators (15)

Madhurendra Singh

Ali Rihani

Styliani Papadaki

Simon Moussaud

Mikael Altun

Teresita Díaz de Ståhl

Jinan Behnan

Ola Söderberg

Martin Kosar

Helena Carén

Johan Heldin

xingqi chen

Robert A Harris

Dimitrios Kanellis

Sylvain Peuget

Make your next move.